D. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.49, issue.1, pp.74-108, 2002.
DOI : 10.3322/canjclin.49.1.33

T. Chan, S. Glockner, J. Yi, W. Chen, L. Van-neste et al., Convergence of Mutation and Epigenetic Alterations Identifies Common Genes in Cancer That Predict for Poor Prognosis, PLoS Medicine, vol.67, issue.5, p.114, 2008.
DOI : 10.1371/journal.pmed.0050114.st004

. Hill, http://www.molecular-cancer.com/content, Molecular Cancer, vol.91, issue.9, p.5151, 2010.

A. Dworkin, T. Huang, and A. Toland, Epigenetic alterations in the breast: Implications for breast cancer detection, prognosis and treatment, Seminars in Cancer Biology, vol.19, issue.3, pp.165-171, 2009.
DOI : 10.1016/j.semcancer.2009.02.007

M. Widschwendter and P. Jones, DNA methylation and breast carcinogenesis, Oncogene, vol.21, issue.35, pp.5462-5482, 2002.
DOI : 10.1038/sj.onc.1205606

A. Richter, G. Pfeifer, and R. Dammann, The RASSF proteins in cancer; from epigenetic silencing to functional characterization, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1796, issue.2, pp.114-128, 2009.
DOI : 10.1016/j.bbcan.2009.03.004

L. Hesson, W. Cooper, and F. Latif, The Role of RASSF1A Methylation in Cancer, Disease Markers, vol.23, issue.1-2, pp.73-87, 2007.
DOI : 10.1155/2007/291538

T. Rauch, H. Li, X. Wu, and G. Pfeifer, MIRA-Assisted Microarray Analysis, a New Technology for the Determination of DNA Methylation Patterns, Identifies Frequent Methylation of Homeodomain-Containing Genes in Lung Cancer Cells, Cancer Research, vol.66, issue.16, pp.7939-7947, 2006.
DOI : 10.1158/0008-5472.CAN-06-1888

T. Rauch, Z. Wang, X. Zhang, X. Zhong, X. Wu et al., Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay, Proceedings of the National Academy of Sciences, vol.104, issue.13, pp.5527-5532, 2007.
DOI : 10.1073/pnas.0701059104

H. Izumi, J. Inoue, S. Yokoi, H. Hosoda, T. Shibata et al., Frequent silencing of DBC1 is by genetic or epigenetic mechanisms in non-small cell lung cancers, Human Molecular Genetics, vol.14, issue.8, pp.997-1007, 2005.
DOI : 10.1093/hmg/ddi092

D. Li, L. Da, H. Tang, T. Li, and M. Zhao, CpG methylation plays a vital role in determining tissue- and cell-specific expression of the human cell-death-inducing DFF45-like effector A gene through the regulation of Sp1/Sp3 binding, Nucleic Acids Research, vol.36, issue.1, pp.330-341, 2008.
DOI : 10.1093/nar/gkm1028

S. Kuang, W. Tong, H. Yang, W. Lin, M. Lee et al., Genome-wide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia, Leukemia, vol.66, issue.8, pp.1529-1538, 2008.
DOI : 10.1038/leu.2008.130

T. Dunwell, L. Hesson, T. Pavlova, V. Zabarovska, V. Kashuba et al., Epigenetic analysis of childhood acute lymphoblastic leukemia, Epigenetics, vol.4, issue.3, pp.185-193, 2009.
DOI : 10.4161/epi.4.3.8752

T. Habuchi, T. Takahashi, H. Kakinuma, L. Wang, N. Tsuchiya et al., Hypermethylation at 9q32-33 tumour suppressor region is age-related in normal urothelium and an early and frequent alteration in bladder cancer, Oncogene, vol.20, issue.4, pp.531-537, 2001.
DOI : 10.1038/sj.onc.1204122

S. Gao, J. Worm, P. Guldberg, H. Eiberg, A. Krogdahl et al., Loss of heterozygosity at 9q33 and hypermethylation of the DBCCR1 gene in oral squamous cell carcinoma, British Journal of Cancer, vol.42
DOI : 10.1034/j.1600-0714.2002.00034.x

S. José-enériz, E. Agirre, X. Román-gómez, J. Cordeu, L. Garate et al., Downregulation of DBC1 expression in acute lymphoblastic leukaemia is mediated by aberrant methylation of its promoter, British Journal of Haematology, vol.59, issue.2, pp.137-144, 2006.
DOI : 10.1016/j.leukres.2005.06.002

M. Mongiat, G. Ligresti, S. Marastoni, E. Lorenzon, R. Doliana et al., Regulation of the Extrinsic Apoptotic Pathway by the Extracellular Matrix Glycoprotein EMILIN2, Molecular and Cellular Biology, vol.27, issue.20, pp.7176-7187, 2007.
DOI : 10.1128/MCB.00696-07

N. Inohara, T. Koseki, S. Chen, X. Wu, and G. Núñez, CIDE, a novel family of cell death activators with homology to the 45kDa subunit of the DNA fragmentation factor, The EMBO Journal, vol.17, issue.9, pp.2526-2533, 1998.
DOI : 10.1093/emboj/17.9.2526

Z. Zhou, Y. Toh, S. Chen, Z. Guo, K. Ng et al., Cidea-deficient mice have lean phenotype and are resistant to obesity, Nature Genetics, vol.35, issue.1, pp.49-56, 2003.
DOI : 10.1038/ng1225

C. Yi, D. Smith, W. West, and M. Hollingsworth, Loss of Fibulin-2 Expression Is Associated with Breast Cancer Progression, The American Journal of Pathology, vol.170, issue.5, pp.1535-1545, 2007.
DOI : 10.2353/ajpath.2007.060478

A. Sadr-nabavi, J. Ramser, J. Volkmann, J. Naehrig, F. Wiesmann et al., Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker, International Journal of Cancer, vol.42, issue.7, pp.1727-1735, 2009.
DOI : 10.1002/ijc.24108

H. Nishiyama, J. Gill, E. Pitt, W. Kennedy, M. Knowles et al., Negative regulation of G1/S transition by the candidate bladder tumour suppressor gene DBCCR1, Oncogene, vol.20, issue.23, pp.2956-29641948, 2001.
DOI : 10.1038/sj.onc.1204432

J. Kohlhase, A. Wischermann, H. Reichenbach, U. Froster, and W. Engel, Mutations in the SALL1 putative transcription factor gene cause Townes-Brocks syndrome, Nature Genetics, vol.9, issue.1, pp.81-83, 1998.
DOI : 10.1038/ng0198-81

M. Argos, M. Kibriya, J. F. Olopade, O. Su, T. Hibshoosh et al., Genomewide scan for loss of heterozygosity and chromosomal amplification in breast carcinoma using single-nucleotide polymorphism arrays, Cancer Genetics and Cytogenetics, vol.182, issue.2, pp.69-74, 2008.
DOI : 10.1016/j.cancergencyto.2008.01.001

S. Chin, Y. Wang, N. Thorne, A. Teschendorff, S. Pinder et al., Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers, Oncogene, vol.23, issue.13, pp.1959-1970, 2007.
DOI : 10.1038/sj.onc.1209985

K. Kittiniyom, K. Gorse, F. Dalbegue, J. Lichy, J. Taubenberger et al., Allelic loss on chromosome band 18p11.3 occurs early and reveals heterogeneity in breast cancer progression, Breast Cancer Research, vol.59, issue.3, pp.192-198, 2001.
DOI : 10.1002/(SICI)1098-2264(199910)26:2<134::AID-GCC5>3.0.CO;2-9

A. Maitra, I. Wistuba, C. Washington, A. Virmani, R. Ashfaq et al., High-Resolution Chromosome 3p Allelotyping of Breast Carcinomas and Precursor Lesions Demonstrates Frequent Loss of Heterozygosity and a Discontinuous Pattern of Allele Loss, The American Journal of Pathology, vol.159, issue.1, pp.119-130, 2001.
DOI : 10.1016/S0002-9440(10)61679-3

E. Braga, V. Senchenko, I. Bazov, W. Loginov, J. Liu et al., Critical tumor-suppressor gene regions on chromosome 3P in major human epithelial malignancies: Allelotyping and quantitative real-time PCR, International Journal of Cancer, vol.76, issue.5, pp.534-541, 2002.
DOI : 10.1002/ijc.10511

J. Karkera, S. Ayache, R. Ransome, . Jr, M. Jackson et al., Refinement of regions with allelic loss on chromosome 18p11.2 and 18q12.2 in esophageal squamous cell carcinoma, Clin Cancer Res, vol.6, pp.3565-3569, 2000.

T. Habuchi, M. Luscombe, P. Elder, and M. Knowles, Structure and Methylation-Based Silencing of a Gene (DBCCR1) within a Candidate Bladder Cancer Tumor Suppressor Region at 9q32???q33, Genomics, vol.48, issue.3, pp.277-288, 1998.
DOI : 10.1006/geno.1997.5165

A. Gazdar, V. Kurvari, A. Virmani, L. Gollahon, M. Sakaguchi et al., Characterization of paired tumor and non-tumor cell lines established from patients with breast cancer, International Journal of Cancer, vol.24, issue.6
DOI : 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L

C. Lewis, B. Herbert, D. Bu, S. Halloway, A. Beck et al., Telomerase immortalization of human mammary epithelial cells derived from a BRCA2 mutation carrier, Breast Cancer Research and Treatment, vol.94, issue.Pt 3, pp.103-115, 2006.
DOI : 10.1007/s10549-006-9189-9

D. Huang, B. Sherman, and R. Lempicki, Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources, Nature Protocols, vol.99, issue.1, pp.44-57, 2009.
DOI : 10.1038/nprot.2008.211

G. Dennis, . Jr, B. Sherman, D. Hosack, Y. J. Gao et al., DAVID: Database for Annotation, Visualization, and Integrated Discovery, Genome Biology, vol.4, issue.5, p.3, 2003.
DOI : 10.1186/gb-2003-4-5-p3

L. Hesson, I. Bieche, D. Krex, E. Criniere, K. Hoang-xuan et al., Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas, Oncogene, vol.23, issue.13, pp.2408-2419, 2004.
DOI : 10.1038/sj.onc.1207407

S. Tozlu-kara, V. Roux, C. Andrieu, J. Vendrell, S. Vacher et al., Oligonucleotide microarray analysis of estrogen receptor ??-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifen, Journal of Molecular Endocrinology, vol.39, issue.4, pp.305-318, 2007.
DOI : 10.1677/JME-07-0001

. Hill, http://www.molecular-cancer.com/content, Molecular Cancer, vol.91, issue.9, p.5151, 2010.